Oil slides after Trump seeks to ease concerns over war’s length

🚁 Red Cat Holdings stock swings after Pentagon drone results cool rally ahead of March 18 earnings

Red Cat Holdings shares whipsawed Monday, losing ground after a public Drone Dominance leaderboard named 11 contenders for prototype contracts.

SUAS News still counted the company’s Teal Drones unit in the mix, but the fresh list cooled a rally that had just sent the stock to its highest point in a year last week.

By mid morning, shares had fallen roughly 4%. The stock opened at $16.08, peaked at $16.78, and then slid to $14.74.

On Friday, they had tagged $18.78, the stock’s highest mark in the last year. TechStock² reports.


⚡ Plug Power eyes AI data center boom with 250 MW PJM hydrogen bid

Plug Power is looking to tap into surging AI data center demand, aiming to supply as much as 250 megawatts of hydrogen fueled electricity in a possible PJM Interconnection auction, no small move on the country’s largest power grid.

To pull it off, the company needs deals of at least seven years.

Talks are already underway between Plug and hyperscalers, data center operators, and utilities, according to Bloomberg.

Shares edged up roughly 0.2% around midday Monday. TechStock² reports.


🚗 What's going on with Synopsys stock Tuesday?

On Tuesday, Synopsys announced the launch of the Synopsys Electronics Digital Twin (eDT) Platform, an open platform designed to accelerate the development of software defined products and physical AI systems.

Initially focused on automotive applications, the platform allows original equipment manufacturers to complete up to 90% of software validation before hardware becomes available, helping shorten development cycles and reduce costs.

“Automotive engineering teams are at their breaking point with more than 600 million lines of software, hundreds of software suppliers, rapidly shrinking development cycles, and mounting cost pressures,” said Ravi Subramanian, Chief Product Management Officer.

“Intelligent system development from vehicles to AI factories requires a fundamentally different approach, one that connects silicon designs to software behavior and full system validation from the earliest stages of development.” Benzinga reports.


🧬 Vertex soars in extended hours after experimental drug shows positive changes in autoimmune kidney disease

Shares of Vertex Pharmaceuticals rose as much as 7% after hours on Monday after the company announced positive 36 week data from its ongoing late stage trial evaluating povetacicept in immunoglobulin A nephropathy.

IgA nephropathy, or Berger’s disease, is an autoimmune kidney disease occurring when immunoglobulin A antibodies deposit in the kidney’s glomeruli, causing inflammation and damage.

The company said that patients treated with povetacicept on top of standard of care achieved a 52% reduction from baseline in urine protein to creatinine ratio at week 36, meeting the study’s key goal.

The reduction was consistent across subgroups, the company said. StockTwits reports.


🔧 TSMC stock jumps pre market on strong sales update, but Iran war jitters keep retail traders cautious

Shares of Taiwan Semiconductor Manufacturing gained 1% in early premarket trading on Tuesday, after the world’s largest contract chip manufacturer said its February sales increased by 22%.

That brings TSMC’s revenue growth for the first two months of the year to about 30%, totaling roughly NT$718.9 billion ($22.6 billion).

Analysts surveyed by Bloomberg expect first quarter growth of around 33%.

The company, which is the chief manufacturer of chips from Nvidia, Advanced Micro Devices, and Broadcom, serves as a barometer for the global AI industry.

The latest performance number also serves as a proxy for Nvidia, the most watched stock in recent times, and for the broader semiconductor industry. StockTwits reports.


🧪 This biotech’s stock soared after a polarizing FDA official is stepping down

A controversial political appointee at the Food and Drug Administration plans to step down for a second time, and the biotech company at the center of a recent debate that involved him saw its stock soar.

UniQure’s stock closed 26% higher on Monday.

Late Friday, the FDA told the Wall Street Journal that Vinay Prasad plans to leave the agency next month.

He is the director of the FDA’s Center for Biologics Evaluation and Research, which oversees vaccines and rare disease drugs.

An FDA spokesperson confirmed his departure. MarketWatch reports.

*Estimate and Actual numbers represent Earnings Per Share in US Dollars


STGW: Stagwell
Q4 2025
Before Market Open
Estimate: 0.260
Actual: N/A

ORCL: Oracle
Q3 2026
After Market Close
Estimate: 1.550
Actual: N/A

CPSS: Consumer Pf Servs
Q4 2025
After Market Close
Estimate: 0.230
Actual: N/A

Time (ET) / Report / Period

6:00 AM - NFIB optimism index - Feb.
10:00 AM - Existing home sales - Feb.

“The stock market is filled with individuals who know the price of everything, but the value of nothing.”

– Philip Fisher

Sourced in: Investing Quotes – Investopedia.

TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).

TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference. There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses. Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.

If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.